Pediatric Movement Disorders of Unknown Etiology in Vietnam (VPeMD) (VPeMD)
Phenotypic and Genotypic Characterization of Pediatric Movement Disorders of Unknown Etiology in Vietnam
This observational patient registry aims to describe the clinical phenotypes and genetic findings of Vietnamese children with movement disorders of unknown etiology. Eligible participants are children with clinically confirmed movement disorders after evaluation by pediatric neurology specialists and after exclusion of clear acquired causes.
The study will collect clinical data, neurological examination findings, available laboratory and imaging results, and video recordings of abnormal movements when consent is provided. Blood samples will be collected for whole-exome sequencing and related genetic analysis. Genetic variants will be classified according to accepted clinical genetics standards and compared with the patients' clinical phenotypes.
The study is expected to improve understanding of the phenotypic and genotypic spectrum of pediatric movement disorders in Vietnam, support genetic counseling, and evaluate how genetic results may influence diagnosis, follow-up, prognosis, and treatment planning.
調査の概要
詳細な説明
Movement disorders in children represent a heterogeneous group of neurological conditions that include dystonia, chorea, ataxia, myoclonus, tremor, tics, parkinsonism, and mixed movement disorders. The underlying causes are highly diverse and include genetic, metabolic, neurodegenerative, structural, immune-mediated, and acquired disorders. However, a substantial proportion of pediatric patients remain without a definitive diagnosis after standard clinical evaluation and routine investigations.
Recent advances in next-generation sequencing technologies, particularly whole-exome sequencing, have significantly improved the diagnostic yield in pediatric movement disorders and have contributed to the identification of novel disease-causing genes and genotype-phenotype correlations. Nevertheless, data regarding the clinical and genetic spectrum of pediatric movement disorders in Vietnam remain limited.
The VPeMD registry is a prospective observational patient registry designed to collect standardized clinical and genetic data from Vietnamese children with movement disorders of unknown etiology. Participants will undergo detailed clinical evaluation by pediatric neurology specialists, including assessment of movement phenomenology, neurological findings, developmental history, family history, neuroimaging findings, laboratory investigations, and treatment history.
Biological samples will be collected for genetic analysis, including whole-exome sequencing and additional molecular investigations when appropriate. Genetic variants will be interpreted according to internationally accepted standards and correlated with clinical manifestations.
The study aims to characterize the phenotypic and genotypic spectrum of pediatric movement disorders in Vietnam, evaluate diagnostic yield of genetic testing, identify genotype-phenotype correlations, and assess the potential impact of genetic diagnosis on patient management, prognosis, genetic counseling, and future therapeutic strategies.
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前：Bich Y L Nguyen, MD, MSc, PhD Candidate
- 電話番号：+84 939077089
- メール：nbylinh.ncs25@ump.edu.vn
研究連絡先のバックアップ
- 名前：Hieu L. T. Nguyen, Assoc Prof, MD, PhD
- 電話番号：+84 908393616
- メール：ngletrunghieu@ump.edu.vn
研究場所
-
-
Ho Chi Minh City
-
Ho Chi Minh City、Ho Chi Minh City、ベトナム、700000
- 募集
- Children's Hospital 1, Ho Chi Minh City
-
コンタクト：
- Linh B.Y Nguyen, MSc, MD, PPHD Candidate
- 電話番号：+84 939077089
- メール：nbylinh.ncs25@ump.edu.vn
-
Ho Chi Minh City、Ho Chi Minh City、ベトナム、700000
- 募集
- University Medical Center Ho Chi Minh City
-
コンタクト：
- Hieu L.T. Nguyen, AProf, MD, PhD
- 電話番号：+84 908393616
- メール：ngletrunghieu@ump.edu.vn
-
-
参加基準
適格基準
就学可能な年齢
- 子
- 大人
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Children younger than 18 years old.
- Patients with clinically confirmed movement disorders based on direct examination and/or video review by at least two pediatric neurology specialists.
- Patients with movement disorders of unknown etiology after appropriate neurological evaluation and exclusion of clear acquired causes.
- Patients evaluated or treated at University Medical Center Ho Chi Minh City or Children's Hospital 1 during the study period.
- Patients and/or legal guardians who provide written informed consent for study participation and genetic testing.
Exclusion Criteria:
- Patients with isolated or transient primary tic disorders.
- Patients with a confirmed acquired cause of movement disorder.
- Patients or legal guardians who decline participation or withdraw from the study.
- Patients with insufficient clinical information or unavailable biological samples for genetic analysis.
研究計画
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Vietnamese Pediatric Movement Disorder Cohort
Vietnamese children with clinically confirmed movement disorders of unknown etiology who meet the study eligibility criteria and are enrolled in the VPeMD registry.
Participants will undergo standardized clinical data collection and genetic testing using whole-exome sequencing.
|
Whole-exome sequencing will be performed on DNA extracted from peripheral blood samples to identify genetic variants associated with pediatric movement disorders.
The test is used for genetic analysis and genotype-phenotype correlation in this observational registry and is not assigned as a treatment intervention.
他の名前：
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Clinical Phenotypes of Pediatric Movement Disorders
時間枠：At enrollment
|
Distribution of clinical movement disorder phenotypes among enrolled participants, including dystonia, chorea, ataxia, myoclonus, tremor, parkinsonism, stereotypies, and mixed movement disorders, based on pediatric neurology assessment and clinical records.
|
At enrollment
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Diagnostic Yield of Whole-Exome Sequencing
時間枠：From enrollment to return of genetic results, up to 12 months
|
Proportion of enrolled participants with pathogenic or likely pathogenic genetic variants identified by whole-exome sequencing and related genetic analysis.
|
From enrollment to return of genetic results, up to 12 months
|
|
Genotype-Phenotype Correlation
時間枠：From enrollment to completion of clinical and genetic data analysis, up to 24 months
|
Correlation between identified genetic variants and clinical phenotypes of pediatric movement disorders will be assessed. Genetic findings will be obtained from WES. Clinical phenotypes will be characterized using standardized neurological assessments, including movement disorder classification, age at onset, symptom distribution, disease progression, neurological comorbidities, developmental status, and neuroimaging findings when available. The correlation between genotype and phenotype will be evaluated by comparing identified genetic variants with clinical characteristics of enrolled participants. |
From enrollment to completion of clinical and genetic data analysis, up to 24 months
|
|
Impact of Genetic Diagnosis on Clinical Management
時間枠：From return of genetic results to follow-up assessment, up to 12 months
|
Proportion of participants whose diagnosis, prognosis, follow-up plan, genetic counseling, or treatment strategy is changed after genetic testing results become available.
|
From return of genetic results to follow-up assessment, up to 12 months
|
協力者と研究者
捜査官
- 主任研究者：Linh B. Y Nguyen, MD, MSc, PHD Candidate、University of Medicine and Pharmacy at Ho Chi Minh City
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- UMP-VPeMD-26298
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。